Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Aug 30, 2024
New HPV vaccine from Zerun Bio receives WHO prequalification
Learn More
Nov 2, 2023
Walvax publishes data from the Phase 3b trial of Walrinvax™ administered in a reduced dosing regimen among adolescent girls in Vaccine
Learn More
Feb 7, 2022
Walvax and Abogen Announce Safety and Immunogenicity Data from Phase 1 Clinical Study of AWcorna (SARS-CoV-2 mRNA Vaccine) Published in The Lancet Microbe
Learn More